オプション
AIプロンプト一覧 哲学/宗教 倫理的意思決定支援

倫理的意思決定支援

{:__('collect %s',倫理的意思決定支援)}

具体的なビジネスの倫理的ジレンマに対し、功利主義と義務論に基づくバランスの取れた分析を提供し、管理者が道徳的に健全な意思決定を行えるよう支援します。

プロンプト内容 コピー コピー

Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.

コピー コピー

以下の具体的なビジネスシナリオについて倫理分析を行ってください:製薬会社が、長期服用後に軽度だが予測可能な副作用があり、患者の心血管リスクを増加させるが、薬を中止すると一部の依存患者の病状が悪化する、ベストセラー医薬品を発見した場合を考えます。功利主義の最大多数の最大幸福の原則と、患者の自律性とインフォームドコンセントを尊重する義務論的要求を組み合わせ、会社が薬の自主回収と副作用の開示を行うべきかどうかを評価してください。利害関係者(患者、株主、従業員、一般大衆)の視点から、短期的な経済的損失と長期的なブランド信頼および法的責任を权衡し、最終的に道徳的責任と企業の持続可能性の両立を図る具体的な行動提案を行い、その提案がどのように各方の利益をバランスさせるかを説明してください。

コピー コピー
コメント (0)
0/300

おすすめ

倫理的意思決定支援
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.
倫理的意思決定支援
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, but discontinuing the drug would lead to more severe health risks. Please evaluate the moral rationality of three options—continuing sales, modifying label warnings, or initiating a recall—by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting patient autonomy, and provide a balanced recommendation that considers both corporate responsibility and patient well-being, ensuring the analysis is logically rigorous and compliant with business ethics standards.
倫理的意思決定支援
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company developing a life-saving new drug faces a situation where clinical trial data is partially missing, yet market demand is urgent. Please analyze the ethical consequences of continuing or pausing the trial by combining utilitarian considerations for the greatest good of the majority with deontological requirements for procedural justice, and provide specific action recommendations that balance legal compliance, social trust, and long-term business sustainability, ensuring the decision-making process is transparent and adheres to the highest industry ethical standards.
倫理的意思決定支援
Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but non-fatal side effects with long-term use, yet withdrawing the product would cause the company to go bankrupt and affect thousands of patients relying on it. Please evaluate the moral weight of three options—withdrawal, continued sales with enhanced warnings, or voluntary recall with compensation—by integrating both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and informed consent) ethical frameworks. Finally, provide a balanced decision recommendation that considers legal compliance, corporate survival, and patient rights, explaining its ethical justification.
倫理的意思決定支援
Please analyze the following specific ethical dilemma encountered in corporate operations: A pharmaceutical company is deciding whether to launch a new drug with high profit margins but minor long-term side effects immediately. Please evaluate the moral weight of different decision paths by combining the principle of maximum happiness in utilitarianism with the requirement of respecting patient autonomy in deontology, and provide a balanced recommendation that considers both business responsibility and social well-being, ensuring the analysis is logically rigorous and aligns with modern business ethics standards.
倫理的意思決定支援
Act as a corporate ethics consultant and analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, yet stopping the medication carries higher risks. Please evaluate the moral weight of three options—recalling, modifying labels, or continuing sales with enhanced monitoring—using both utilitarian and deontological ethical frameworks, and provide a balanced recommendation that considers both shareholder interests and patient well-being, focusing on the ethical logic behind the decision rather than mere legal compliance.
OR